✦ LIBER ✦

Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients

✍ Scribed by Diab, Dima L.; Yerian, Lisa; Schauer, Philip; Kashyap, Sangeeta R.; Lopez, Rocio; Hazen, Stanley L.; Feldstein, Ariel E.

Book ID: 123104789
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 534 KB
Volume: 6
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2008.07.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytokeratin-18 fragment levels as noninv

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study

✍ Ariel E. Feldstein; Anna Wieckowska; A. Rocio Lopez; Yao-Chang Liu; Nizar N. Zei 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

Liver biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH). We have recently demonstrated that plasma cytokeratin 18 (CK-18) fragment levels correlate with the magnitude of hepatocyte apoptosis and independently predict the presence of NASH. The goal of this study was

Serum cytokeratin-18 fragment level: A n

Serum cytokeratin-18 fragment level: A noninvasive biomarker for not only nonalcoholic steatohepatitis, but also alcoholic steatohepatitis

✍ Xiaohua Li; Ying Zhang; Kaichun Wu; Daiming Fan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

We read with great interest the article by Petta et al. 1 The compound 25-hydroxyvitamin D3 (25[OH]D3) was reported as an independent predictor of cardiovascular disease (by a decreased expression of profibrotic markers, and an increased expression of antifibrotic markers) despite the fact that its

Serum Cytokeratin-18 Fragment Levels Are

Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children

✍ Feldstein, Ariel E; Alkhouri, Naim; De Vito, Rita; Alisi, Anna; Lopez, Rocio; No 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 205 KB

The cytokeratin-18 fragment level as a b

The cytokeratin-18 fragment level as a biomarker of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

✍ Miyasato, Mai; Murase-Mishiba, Yuko; Bessho, Megumi; Miyawaki, Masahiro; Imbe, H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Atorvastatin decreases serum levels of a

Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH

✍ Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Is 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 202 KB